Biomedical Engineering Reference
In-Depth Information
[11] Bowey K, Tanguay Jf, Tabrizian m. Liposome technology for cardiovascular disease
treatment and diagnosis. Expert opin drug deliv 2012;
9
:249-265.
[12] silindir m, ozer AY, Erdogan s. The use and importance of liposomes in positron
Emission Tomography. drug deliv 2012;
19
:68-80.
[13] Torchilin Vp. Nanocarriers. pharm res 2007;
24
:2333-2334.
[14] Torchilin Vp. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
AAps J 2007;
9
:E128-E147.
[15] Elbayoumi TA, Torchilin Vp. Current trends in liposome research. in: Weissig V, editor.
Liposomes
. Totowa: springer & Humana press; 2009.
[16] Kirpotin dB, drummond dC, shao Y, shalaby mr, Hong K, Nielsen uB, marks Jd,
Benz CC, park JW. Antibody targeting of long-circulating lipidic nanoparticles does not
increase tumor localization but does increase internalization in animal models. Cancer
res 2006;
66
:6732-6740.
[17] Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related com-
pounds. Adv drug deliv rev 2002;
54
:203-222.
[18] Torchilin Vp. micellar nanocarriers: pharmaceutical perspectives. pharm res 2007;
24
:
1-16.
[19] Torchilin Vp. Lipid-core micelles for targeted drug delivery. Curr drug deliv 2005;
2
:
319-327.
[20] phillips WT. delivery of gamma-imaging agents by liposomes. Adv drug deliv rev
1999;
37
:13-32.
[21] goins B, phillips T. radiolabeled liposomes for imaging and biodistribution studies. in:
Torchilin V, Weissig V, editors.
Liposomes: A Practical Approach
. 2nd ed. London:
oxford university press; 2003. p 319-336.
[22] Hnatowich dJ, friedman B, Clancy B, Novak m. Labeling of preformed liposomes with
ga-67 and Tc-99m by chelation. J Nucl med 1981;
22
:810-814.
[23] Caride VJ, Taylor W, Cramer JA, gottschalk A. Evaluation of liposome-entrapped radio-
active tracers as scanning agents. part 1: organ distribution of liposome (99mTc-dTpA)
in mice. J Nucl med 1976;
17
:1067-1072.
[24] Torchilin Vp, Trubetskoy Vs.
In vivo
visualizing of organs and tissues with liposomes.
J Liposome res 1995;
5
:795-812.
[25] oku N. delivery of contrast agents for positron emission tomography imaging by lipo-
somes. Adv drug deliv rev 1999;
37
:53-61.
[26] goins BA, phillips WT. The use of scintigraphic imaging as a tool in the development of
liposome formulations. prog Lipid res 2001;
40
:95-123.
[27] patel Hm, Boodle Km, Vaughan-Jones r. Assessment of the potential uses of liposomes
for lymphoscintigraphy and lymphatic drug delivery. failure of 99m-technetium marker
to represent intact liposomes in lymph nodes. Biochim Biophys Acta 1984;
801
:76-86.
[28] damen J, regts J, scherphof g. Transfer and exchange of phospholipid between
small unilamellar liposomes and rat plasma high density lipoproteins. dependence on
cholesterol content and phospholipid composition. Biochim Biophys Acta 1981;
665
:
538-545.
[29] morgan Jr, Williams KE, davies rL, Leach K, Thomson m, Williams LA. Localisation
of experimental staphylococcal abscesses by 99mTC-technetium-labelled liposomes.
J med microbiol 1981;
14
:213-217.
Search WWH ::
Custom Search